• Company
• 20-valent pneumococcal conjugate vaccine to enter market
• by Whang, byung-woo Nov 8, 2024 05:47am

• Company
• Optivo's clinical results for Koreans with gastric cancer
• by Son, Hyung Min Nov 8, 2024 05:47am

• Company
• Geo-Young and UBC Korea sign MOU to distribute Bimzelx
• by Son, Hyung Min Nov 8, 2024 05:47am

• Company
• Novo Nordisk tops KRW 14T in sales, thanks to Wegovy
• by Whang, byung-woo Nov 8, 2024 05:46am

• Company
• Oral psoriasis drug 'Sotyktu' lands at Big 5 hospitals
• by Son, Hyung Min Nov 8, 2024 05:46am

• Company
• Reimb discussions discontinued for NMOSD drug Uplizna
• by Eo, Yun-Ho Nov 7, 2024 05:47am

• Company
• 20-valent pneumococcal conjugate vaccine set to launch
• by Moon, sung-ho Nov 6, 2024 05:52am

• Company
• Roche seeks digital solutions for its healthcare ecosystem
• by Whang, byung-woo Nov 6, 2024 05:52am

• Company
• CKD’s CKD-508 receives approval to initiate P1T in the U.S.
• by Son, Hyung Min Nov 6, 2024 05:52am

• Company
• Amgen's Prolia·Evenity generate KRW 2T in quarterly sales
• by Son, Hyung Min Nov 6, 2024 05:52am